Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma (FIDES-01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03230318
Recruitment Status : Recruiting
First Posted : July 26, 2017
Last Update Posted : February 1, 2021
Sponsor:
Information provided by (Responsible Party):
Basilea Pharmaceutica